KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to $125.6 million.

  • Acadia Pharmaceuticals' Change in Acquisitions & Divestments rose 8174.96% to $125.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $499.6 million, marking a year-over-year increase of 5590.26%. This contributed to the annual value of $328.6 million for FY2024, which is 2355.04% down from last year.
  • Acadia Pharmaceuticals' Change in Acquisitions & Divestments amounted to $125.6 million in Q3 2025, which was up 8174.96% from $131.4 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Change in Acquisitions & Divestments registered a high of $259.4 million during Q1 2023, and its lowest value of $7.5 million during Q2 2023.
  • In the last 5 years, Acadia Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $103.8 million in 2023 and averaged $105.5 million.
  • As far as peak fluctuations go, Acadia Pharmaceuticals' Change in Acquisitions & Divestments plummeted by 8922.1% in 2023, and later skyrocketed by 98666.67% in 2024.
  • Quarter analysis of 5 years shows Acadia Pharmaceuticals' Change in Acquisitions & Divestments stood at $110.5 million in 2021, then plummeted by 31.4% to $75.8 million in 2022, then skyrocketed by 36.89% to $103.8 million in 2023, then grew by 7.8% to $111.8 million in 2024, then grew by 12.28% to $125.6 million in 2025.
  • Its last three reported values are $125.6 million in Q3 2025, $131.4 million for Q2 2025, and $130.8 million during Q1 2025.